Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

Placebo testing has been part of the process since the 1940s. It’s unclear what additional measures would achieve — but it may slow development.

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...

The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.

The head of the FDA reiterated that the agency is applying a more skeptical approach to this year’s round of COVID-19 vaccine boosters.

The Trump administration has launched a $500 million project to develop a universal flu vaccine that won't need yearly ...

MPox is endemic in DRC, and has continued to cause large numbers of cases in the WHO African Region. In April, 2025, the WHO has restated that MPox continues to be a Public Health Emergency of ...

The United States is advising travellers aged 60 and up to hold off on getting the chikungunya vaccine while it looks into ...

A half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...

UW Health's Dr. Jeff Pothof discusses FDA-approved food dyes, a new tool to test for HPV at home and the shingles vaccine.

Robert F. Kennedy Jr. will testify before Congress on Wednesday for the first time since taking the role of U.S. health ...